{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:51:13Z","timestamp":1790653873495,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1124\/jpet.123.001942","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T18:40:14Z","timestamp":1706208014000},"page":"14-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents"],"prefix":"10.1016","volume":"390","author":[{"given":"Hannah E.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-2400","authenticated-orcid":false,"given":"Brenda M.","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Carbonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-3000","authenticated-orcid":false,"given":"Chad R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-1593","authenticated-orcid":false,"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001942_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00213-019-05412-y","article-title":"4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels","volume":"237","author":"Abiero","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001942_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.123.001942_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jat\/bky097","article-title":"Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases","volume":"43","author":"Ameline","year":"2019","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001942_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/20961790.2021.1928821","article-title":"Determination of 3-MeO-PCP in human blood and urine in a fatal intoxication case, with a specific focus on metabolites identification","volume":"6","author":"Arbouche","year":"2021","journal-title":"Forensic Sci Res"},{"key":"10.1124\/jpet.123.001942_bib7","first-page":"270","article-title":"Behavioral pharmacology of PCP, NMDA and sigma receptors","volume":"95","author":"Balster","year":"1989","journal-title":"NIDA Res Monogr"},{"issue":"Pt A","key":"10.1124\/jpet.123.001942_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2017.08.028","article-title":"Phencyclidine-like in vivo effects of methoxetamine in mice and rats","volume":"134","author":"Berquist","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001942_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pbb.2015.03.007","article-title":"Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential","volume":"133","author":"Botanas","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.123.001942_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0091-3057(81)90245-8","article-title":"Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey","volume":"14","author":"Brady","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.123.001942_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0091-3057(82)90083-1","article-title":"Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats","volume":"17","author":"Brady","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.123.001942_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130050207","article-title":"Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data","volume":"130","author":"Brauer","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001942_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","author":"Buben\u00edkov\u00e1-Valesov\u00e1","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.123.001942_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/ADM.0000000000000390","article-title":"Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder","volume":"12","author":"Caloro","year":"2018","journal-title":"J Addict Med"},{"key":"10.1124\/jpet.123.001942_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0024-3205(97)00228-2","article-title":"Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications","volume":"61","author":"Carlsson","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001942_bib16A","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/jm00141a006","article-title":"Phencyclidine metabolism: resolution, structure, and biological activity of the isomers of the hydroxy metabolite, 4-phenyl-4-(1-piperidinyl)cyclohexanol","volume":"24","author":"Carroll","year":"1981","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001942_bib16","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00414-022-02818-w","article-title":"Intoxication by 3-MeO-PCP and O-desmethyltramadol: an unusual NPS mix","volume":"136","author":"Castro","year":"2022","journal-title":"Int J Legal Med"},{"key":"10.1124\/jpet.123.001942_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00952990.2022.2132506","article-title":"Overdoses and deaths related to the use of ketamine and its analogues: a systematic review","volume":"49","author":"Chaves","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2\u20133 Spec Issue","key":"10.1124\/jpet.123.001942_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/FBP.0000000000000221","article-title":"The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats","volume":"27","author":"Chiamulera","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.123.001942_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(25)21490-2","article-title":"Structure-activity relationship studies of phencyclidine derivatives in rats","volume":"228","author":"Cone","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jat\/bkac015","article-title":"The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature","volume":"46","author":"Copeland","year":"2022","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001942_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1213\/00000539-196005000-00015","article-title":"Intravenous nonbarbiturate, nonnarcotic analgesics: preliminary studies. 1. Cyclohexylamines","volume":"39","author":"Collins","year":"1960","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.123.001942_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/1097-4679(199101)47:1<159::AID-JCLP2270470125>3.0.CO;2-O","article-title":"Recovery of neuropsychological functions during reduction in use of phencyclidine","volume":"47","author":"Cosgrove","year":"1991","journal-title":"J Clin Psychol"},{"key":"10.1124\/jpet.123.001942_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/dta.2807","article-title":"In vitro and in vivo metabolism and detection of 3-HO-PCP, a synthetic phencyclidine, in human samples and pooled human hepatocytes using high resolution mass spectrometry","volume":"12","author":"Davidsen","year":"2020","journal-title":"Drug Test Anal"},{"key":"10.1124\/jpet.123.001942_bib24","first-page":"A7358","article-title":"[A patient in a methoxetamine-induced dissociative psychosis]","volume":"158","author":"de Jong","year":"2014","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1124\/jpet.123.001942_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.aca.2018.12.014","article-title":"Differentiation of fentanyl analogues by low-field NMR spectroscopy","volume":"1049","author":"Duffy","year":"2019","journal-title":"Anal Chim Acta"},{"key":"10.1124\/jpet.123.001942_bib26","doi-asserted-by":"crossref","first-page":"618339","DOI":"10.3389\/fchem.2020.618339","article-title":"Analytical Characterization of 3-MeO-PCP and 3-MMC in Seized Products and Biosamples: The Role of LC-HRAM-Orbitrap-MS and Solid Deposition GC-FTIR","volume":"8","author":"Frison","year":"2021","journal-title":"Front Chem"},{"key":"10.1124\/jpet.123.001942_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1749-6632.1978.tb31518.x","article-title":"Structure-activity relationships among the halogenated amphetamines","volume":"305","author":"Fuller","year":"1978","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001942_bib29a","doi-asserted-by":"crossref","first-page":"110917","DOI":"10.1016\/j.drugalcdep.2023.110917","article-title":"Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety","volume":"250","author":"Gannon","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.123.001942_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drugalcdep.2019.02.016","article-title":"Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats","volume":"199","author":"Gatch","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.123.001942_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3565(25)21501-4","article-title":"A novel phencyclidine analog interacts selectively with mu opioid receptors","volume":"230","author":"Itzhak","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib32b","series-title":"PCP (Phencycidine): Historical and Current Perspectives","first-page":"331","article-title":"Interdisciplinary studies on phencyclidine","author":"Jasinski","year":"1981"},{"key":"10.1124\/jpet.123.001942_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.123.001942_bib32","series-title":"StatPearls","article-title":"Dextromethorphan Toxicity","author":"Journey","year":"2022"},{"key":"10.1124\/jpet.123.001942_bib32a","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00376a006","article-title":"N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties","volume":"27","author":"Kalir","year":"1984","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001942_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(25)13197-2","article-title":"N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis","volume":"253","author":"Koek","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13171","article-title":"2-Fluorodeschloroketamine has similar abuse potential as ketamine","volume":"27","author":"Li","year":"2022","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.123.001942_bib35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/dta.2264","article-title":"The identification and analytical characterization of 2,2\u2032-difluorofentanyl","volume":"10","author":"Liu","year":"2018","journal-title":"Drug Test Anal"},{"key":"10.1124\/jpet.123.001942_bib36","doi-asserted-by":"crossref","first-page":"111450","DOI":"10.1016\/j.forsciint.2022.111450","article-title":"The application of 19F NMR spectroscopy for the analysis of fluorinated new psychoactive substances (NPS)","volume":"340","author":"Liu","year":"2022","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.123.001942_bib37","first-page":"273","article-title":"New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic","volume":"12","author":"Lo Faro","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1124\/jpet.123.001942_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug; sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1124\/jpet.123.001942_bib39","first-page":"59","article-title":"Dextromethorphan in Cough Syrup: The Poor Man\u2019s Psychosis","volume":"47","author":"Martinak","year":"2017","journal-title":"Psychopharmacol Bull"},{"key":"10.1124\/jpet.123.001942_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00008877-199204000-00007","article-title":"Effects of phencyclidine-like drugs on responding under multiple fixed ratio, fixed interval schedules","volume":"3","author":"McMillan","year":"1992","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.123.001942_bib40A","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1021\/jm00144a011","article-title":"Structure-activity relationships of the cycloalkyl ring of phencyclidine","volume":"24","author":"McQuinn","year":"1981","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001942_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00216066","article-title":"Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites","volume":"96","author":"Middaugh","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001942_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/02791072.2019.1578444","article-title":"Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET\/CT Case Study","volume":"51","author":"Moccia","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"10.1124\/jpet.123.001942_bib43","doi-asserted-by":"crossref","first-page":"110888","DOI":"10.1016\/j.forsciint.2021.110888","article-title":"Detection of 4-FMC, 4-MeO-\u03b1-PVP, 4-F-\u03b1-PVP, and PV8 in blood in a forensic case using liquid chromatography-electrospray ionization linear ion trap mass spectrometry","volume":"325","author":"Mochizuki","year":"2021","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.123.001942_bib44","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00213-016-4275-0","article-title":"The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission","volume":"233","author":"Mutti","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001942_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12981","article-title":"The dopaminergic alterations induced by 4-F-PCP and 4-Keto-PCP may enhance their drug-induced rewarding and reinforcing effects: Implications for abuse","volume":"26","author":"Ortiz","year":"2021","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.123.001942_bib46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamapsychiatry.2023.1423","article-title":"Trends in Illicit Ketamine Seizures in the US From 2017 to 2022","volume":"80","author":"Palamar","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/jpet.123.001942_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/1531-8249(200010)48:4<556::AID-ANA2>3.0.CO;2-2","article-title":"Neurobiology of schizophrenia","volume":"48","author":"Pearlson","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001942_bib48","doi-asserted-by":"crossref","first-page":"110135","DOI":"10.1016\/j.forsciint.2019.110135","article-title":"Identifying PCP and four PCP analogs using the gold chloride microcrystalline test followed by raman microspectroscopy and chemometrics","volume":"307","author":"Quinn","year":"2020","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.123.001942_bib49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1176\/ajp.132.10.1076","article-title":"Prolonged psychosis attributed to phencyclidine: report of three cases","volume":"132","author":"Rainey","year":"1975","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.123.001942_bib49a","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3565(25)33112-5","article-title":"Intravenous self-administration of phencyclidine and related compounds in the dog","volume":"221","author":"Risner","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008877-199811000-00005","article-title":"Homology in behavioural pharmacology: an approach to animal models of human cognition","volume":"9","author":"Robbins","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.123.001942_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059334","article-title":"The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor","volume":"8","author":"Roth","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001942_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3565(25)28710-9","article-title":"P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin","volume":"175","author":"Sanders-Bush","year":"1970","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib52a","doi-asserted-by":"crossref","first-page":"173527","DOI":"10.1016\/j.ejphar.2020.173527","article-title":"The potential rewarding and reinforcing effects of the substituted benzofurans 2-EAPB and 5-EAPB in rodents","volume":"885","author":"Sayson","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001942_bib53","series-title":"Transduction mechanisms of drug stimuli","first-page":"161","article-title":"Relationship between the discriminative stimulus properties and subjective effects of drugs","author":"Schuster","year":"1988"},{"key":"10.1124\/jpet.123.001942_bib53a","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(25)32463-8","article-title":"Evaluation of Phencyclidine Analogs on the Basis of Their Discriminative Stimulus Properties in the Rat","volume":"216","author":"Shannon","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib53b","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-3565(25)32631-5","article-title":"Effects of N-substituted analogs and metabolites of phencyclidine on avoidance behavior in the rat","volume":"218","author":"Shannon","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib54A","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0022-3565(25)33474-9","article-title":"Effects of cycloalkyl ring analogs of phencyclidine on behavior in rodents","volume":"224","author":"Shannon","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001942_bib54","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ajhp\/59.11.1067","article-title":"Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate","volume":"59","author":"Smith","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/jpet.123.001942_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","article-title":"Realistic expectations of prepulse inhibition in translational models for schizophrenia research","volume":"199","author":"Swerdlow","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001942_bib56","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/0269881116661075","article-title":"Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next","volume":"30","author":"Swerdlow","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.123.001942_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/dar.13237","article-title":"Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings","volume":"40","author":"Ti","year":"2021","journal-title":"Drug Alcohol Rev"},{"key":"10.1124\/jpet.123.001942_bib57a","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1073\/pnas.76.9.4678","article-title":"Interaction of phencyclidine (\u201cangel dust\u201d) with a specific receptor in rat brain membranes","volume":"76","author":"Vincent","year":"1979","journal-title":"Proc Nat Acad Sci"},{"key":"10.1124\/jpet.123.001942_bib58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jat\/bkad016","article-title":"Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID","volume":"47","author":"Watanabe","year":"2023","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.123.001942_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12640-020-00227-8","article-title":"Four Synthetic Cathinones: 3-Chloromethcathinone, 4-Chloromethcathinone, 4-Fluoro-\u03b1-Pyrrolidinopentiophenone, and 4-Methoxy-\u03b1-Pyrrolidinopentiophenone Produce Changes in the Spontaneous Locomotor Activity and Motor Performance in Mice with Varied Profiles","volume":"38","author":"Wojcieszak","year":"2020","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.123.001942_bib60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/metabo13040576","article-title":"Study of the Metabolic Profiles of \u201cIndazole-3-Carboxamide\u201d and \u201cIsatin Acyl Hydrazone\u201d (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS","volume":"13","author":"Xiang","year":"2023","journal-title":"Metabolites"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:04:33Z","timestamp":1739959473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0022356524001836"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001942","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}